Cargando…

Hematopoietic lineage cell-specific protein 1 (HS1), a hidden player in migration, invasion, and tumor formation, is over-expressed in ovarian carcinoma cells

Hematopoietic lineage cell-specific protein 1 (HS1), which is the hematopoietic homolog of cortactin, is an actin-binding protein and Lyn substrate. It is upregulated in several cancers and its expression level is associated with increased cell migration, metastasis, and poor prognosis. Here we inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koya, Yoshihiro, Liu, Wenting, Yamakita, Yoshihiko, Senga, Takeshi, Shibata, Kiyosumi, Yamashita, Mamoru, Nawa, Akihiro, Kikkawa, Fumitaka, Kajiyama, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135686/ https://www.ncbi.nlm.nih.gov/pubmed/30220969 http://dx.doi.org/10.18632/oncotarget.25975

Ejemplares similares

GPC3 expression in mouse ovarian cancer induces GPC3-specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth
por: LUO, CHENHONG, et al.
Publicado: (2014)

Ovarian cancer‐associated mesothelial cells induce acquired platinum‐resistance in peritoneal metastasis via the FN1/Akt signaling pathway
por: Yoshihara, Masato, et al.
Publicado: (2020)

Folate‐appended cyclodextrin carrier targets ovarian cancer cells expressing the proton‐coupled folate transporter
por: Saito, Shinichi, et al.
Publicado: (2020)

Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer
por: Tsukamoto, Hirohisa, et al.
Publicado: (2008)

Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells
por: Terauchi, Mikio, et al.
Publicado: (2007)

P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling
por: Shibata, Kiyosumi, et al.
Publicado: (2007)

Growing Teratoma Syndrome of the Ovary Showing Three Patterns of Metastasis: A Case Report
por: Shibata, Kiyosumi, et al.
Publicado: (2013)

Inhibition of ZEB1 leads to inversion of metastatic characteristics and restoration of paclitaxel sensitivity of chronic chemoresistant ovarian carcinoma cells
por: Sakata, Jun, et al.
Publicado: (2017)

HOXB13 and ALX4 induce SLUG expression for the promotion of EMT and cell invasion in ovarian cancer cells
por: Yuan, Hong, et al.
Publicado: (2015)

Estrogen producing ovarian fibrosarcoma: A case report
por: Miura, Mayo, et al.
Publicado: (2019)

KIF20A expression as a prognostic indicator and its possible involvement in the proliferation of ovarian clear-cell carcinoma cells
por: Kawai, Yosuke, et al.
Publicado: (2018)

The impact of systematic retroperitoneal lymphadenectomy on long-term oncologic outcome of women with advanced ovarian clear-cell carcinoma
por: Kajiyama, Hiroaki, et al.
Publicado: (2020)

Significant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy: Two case reports
por: Suzuki, Shiro, et al.
Publicado: (2014)

Clinicopathologic features of epithelial ovarian carcinoma in younger vs. older patients: analysis in Japanese women
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2014)

Dengue fever during pregnancy
por: Tien Dat, Trinh, et al.
Publicado: (2018)

Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma
por: Suzuki, Shiro, et al.
Publicado: (2016)

Extracellular miRNAs as Predictive Biomarkers for Glypican-3-Derived Peptide Vaccine Therapy Response in Ovarian Clear Cell Carcinoma
por: Ukai, Mayu, et al.
Publicado: (2021)

Ovarian Cancer-Associated Mesothelial Cells: Transdifferentiation to Minions of Cancer and Orchestrate Developing Peritoneal Dissemination
por: Mogi, Kazumasa, et al.
Publicado: (2021)

Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer ~propensity score- matched analysis~
por: Kajiyama, Hiroaki, et al.
Publicado: (2019)

PRIMA-1(MET) induces apoptosis through accumulation of intracellular reactive oxygen species irrespective of p53 status and chemo-sensitivity in epithelial ovarian cancer cells
por: YOSHIKAWA, NOBUHISA, et al.
Publicado: (2016)

Microphthalmia-Associated Transcription Factor-Dependent Melanoma Cell Adhesion Molecule Activation Promotes Peritoneal Metastasis of Ovarian Cancer
por: Kitami, Kazuhisa, et al.
Publicado: (2020)

Comparison of prognoses according to non‐positive and positive spectrin αII expression detected immunohistochemically in epithelial ovarian carcinoma: a retrospective study.
por: Maeda, Osamu, et al.
Publicado: (2016)

Postoperative chemoradiation therapy using high dose cisplatin and fluorouracil for high- and intermediate-risk uterine cervical cancer
por: Miyauchi, Rise, et al.
Publicado: (2017)

9-oxo-ODAs suppresses the proliferation of human cervical cancer cells through the inhibition of CDKs and HPV oncoproteins
por: Mogi, Kazumasa, et al.
Publicado: (2023)

Metastatic Voyage of Ovarian Cancer Cells in Ascites with the Assistance of Various Cellular Components
por: Uno, Kaname, et al.
Publicado: (2022)

Establishment and characterization of cell lines derived from complete hydatidiform mole
por: Yamamoto, Eiko, et al.
Publicado: (2017)

Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival
por: Ino, K, et al.
Publicado: (2006)

The Therapeutic Effects of Goreisan, a Traditional Japanese Herbal Medicine, on Lower-Limb Lymphedema after Lymphadenectomy in Gynecologic Malignancies: A Case Series Study
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2020)

Survival benefit of taxane plus platinum in recurrent ovarian cancer with non-clear cell, non-mucinous histology
por: Kajiyama, Hiroaki, et al.
Publicado: (2014)

The prognostic impact of pulmonary metastasectomy in recurrent gynecologic cancers: a retrospective single-institution study
por: Adachi, Manabu, et al.
Publicado: (2015)

Expression of Twist increases the risk for recurrence and for poor survival in epithelial ovarian carcinoma patients
por: Hosono, S, et al.
Publicado: (2007)

Regulation of Mesothelial Cell Fate during Development and Human Diseases
por: Taniguchi, Toshiaki, et al.
Publicado: (2022)

Suppression of REV7 enhances cisplatin sensitivity in ovarian clear cell carcinoma cells
por: Niimi, Kaoru, et al.
Publicado: (2014)

Fertility-sparing surgery of malignant transformation arising from mature cystic teratoma of the ovary
por: Yoshikawa, Nobuhisa, et al.
Publicado: (2018)

Regulation of secondary follicle growth by theca cells and insulin-like growth factor 1
por: SHIOMI-SUGAYA, Noriko, et al.
Publicado: (2015)

Long-term survival of young women receiving fertility-sparing surgery for ovarian cancer in comparison with those undergoing radical surgery
por: Kajiyama, H, et al.
Publicado: (2011)

The management of hydatidiform mole using prophylactic chemotherapy and hysterectomy for high-risk patients decreased the incidence of gestational trophoblastic neoplasia in Vietnam: a retrospective observational study
por: Yamamoto, Eiko, et al.
Publicado: (2020)

Epidemiological overview of metastatic ovarian carcinoma: long-term experience of TOTSG database
por: Kajiyama, Hiroaki, et al.
Publicado: (2019)

The possible existence of occult metastasis in patients with ovarian clear-cell carcinoma who underwent complete resection without any residual tumours
por: Kajiyama, Hiroaki, et al.
Publicado: (2018)

Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis
por: Yamamoto, E, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_5sendu0hsdgv74qmnuvmldvrq9